Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel

Clinical and Translational Immunology

Volumn 5, Issue 1, 2016, Pages

  Ohradanova Repic, Anna ^a   Machacek, Christian ^a   Fischer, Michael B ^b,c   Stockinger, Hannes ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY; T6 ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; MONONUCLEAR PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL;

EID: 85047769318     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/cti.2015.39     Document Type: Article

References (50)

1. Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 2014; 14: 392–404.
2. Reynolds G, Haniffa M. Human and mouse mononuclear phagocyte networks: a tale of two species? Front Immunol 2015; 6: 330.
3. Schlitzer A, McGovern N, Ginhoux F. Dendritic cells and monocyte-derived cells: two complementary and integrated functional systems. Semin Cell Dev Biol 2015; 41: 9–22.
4. Lee J, Breton G, Oliveira TY, Zhou YJ, Aljoufi A, Puhr S et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med 2015; 212: 385–399.
5. Breton G, Lee J, Zhou YJ, Schreiber JJ, Keler T, Puhr S et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells. J Exp Med 2015; 212: 401–413.
6. Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity 2014; 41: 21–35.
7. McGovern N, Schlitzer A, Gunawan M, Jardine L, Shin A, Poyner E et al. Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages. Immunity 2014; 41: 465–477.
8. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 2014; 14: 571–578.
9. Haniffa M, Bigley V, Collin M. Human mononuclear phagocyte system reunited. Semin Cell Dev Biol 2015; 41: 59–69.
10. Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013; 38: 336–348.
11. Kasinrerk W, Baumruker T, Majdic O, Knapp W, Stockinger H. CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol 1993; 150: 579–584.
12. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109–1118.
13. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41: 14–20.
14. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677–686.
15. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014; 40: 274–288.
16. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560–4565.
17. Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, Longo N et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol 2002; 168: 2634–2643.
18. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM et al. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010; 24: 665–683.
19. Klimosch SN, Bartel Y, Wiemann S, Steinle A. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses. Blood 2013; 122: 2380–2389.
20. Chan DV, Somani AK, Young AB, Massari JV, Ohtola J, Sugiyama H et al. Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32). BMC Biochem 2011; 12: 27.
21. Schraven B, Schoenhaut D, Bruyns E, Koretzky G, Eckerskorn C, Wallich R et al. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J Biol Chem 1994; 269: 29102–29111.
22. Sengupta S, Thaci B, Crawford AC, Sampath P. Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy. Biomed Res Int 2014; 2014: 952128.
23. de Bock CE, Ardjmand A, Molloy TJ, Bone SM, Johnstone D, Campbell DM et al. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia 2012; 26: 918–926.
24. Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H et al. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 2006; 177: 40–44.
25. Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari et al. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-gamma contributes to modulate immune responses. J Biol Chem 2011; 286: 37964–37975.
26. Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol 2013; 190: 66–79.
27. Bates EE, Dieu MC, Ravel O, Zurawski SM, Patel S, Bridon JM et al. CD40L activation of dendritic cells down-regulates DORA, a novel member of the immunoglobulin superfamily. Mol Immunol 1998; 35: 513–524.
28. Cao W, Rosen DB, Ito T, Bover L, Bao M, Watanabe G et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 2006; 203: 1399–1405.
29. Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood 2012; 119: 2284–2292.
30. Bauer T, Zagorska A, Jurkin J, Yasmin N, Koffel R, Richter S et al. Identification of Axl as a downstream effector of TGF-beta1 during Langerhans cell differentiation and epidermal homeostasis. J Exp Med 2012; 209: 2033–2047.
31. Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, Umetsu SE et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007; 27: 927–940.
32. Sonar SS, Hsu YM, Conrad ML, Majeau GR, Kilic A, Garber E et al. Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J Clin Invest 2010; 120: 2767–2781.
33. De Palma M, Mazzieri R, Politi LS, Pucci F, Zonari E, Sitia G et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 2008; 14: 299–311.
34. Kato M, Khan S, d'Aniello E, McDonald KJ, Hart DN. The novel endocytic and phagocytic C-Type lectin receptor DCL-1/CD302 on macrophages is colocalized with F-actin, suggesting a role in cell adhesion and migration. J Immunol 2007; 179: 6052–6063.
35. Waechter V, Schmid M, Herova M, Weber A, Gunther V, Marti-Jaun J et al. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages. J Immunol 2012; 188: 1856–1867.
36. Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 2012; 30: 491–529.
37. Yan H, Kamiya T, Suabjakyong P, Tsuji NM. Targeting C-type lectin receptors for cancer immunity. Front Immunol 2015; 6: 408.
38. Sobanov Y, Bernreiter A, Derdak S, Mechtcheriakova D, Schweighofer B, Duchler M et al. A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur J Immunol 2001; 31: 3493–3503.
39. Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S et al. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 2005; 35: 1539–1547.
40. Willment JA, Lin HH, Reid DM, Taylor PR, Williams DL, Wong SY et al. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol 2003; 171: 4569–4573.
41. Graham LM, Gupta V, Schafer G, Reid DM, Kimberg M, Dennehy KM et al. The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through Syk kinase. J Biol Chem 2012; 287: 25964–25974.
42. Zhu LL, Zhao XQ, Jiang C, You Y, Chen XP, Jiang YY et al. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 2013; 39: 324–334.
43. Miyake Y, Masatsugu OH, Yamasaki S. C-type lectin receptor MCL facilitates mincle expression and signaling through complex formation. J Immunol 2015; 194: 5366–5374.
44. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008; 453: 672–676.
45. Joyce-Shaikh B, Bigler ME, Chao CC, Murphy EE, Blumenschein WM, Adamopoulos IE et al. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med 2010; 207: 579–589.
46. Marshall AS, Willment JA, Lin HH, Williams DL, Gordon S, Brown GD. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J Biol Chem 2004; 279: 14792–14802.
47. Marshall AS, Willment JA, Pyz E, Dennehy KM, Reid DM, Dri P et al. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur J Immunol 2006; 36: 2159–2169.
48. Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, Pin JJ et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol 1999; 163: 1973–1983.
49. Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O'Bar et al. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 2010; 116: 1685–1697.
50. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol 2012; 188: 5752–5765.